Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Department of Health and Human Services National Institutes of Health
Type
Research/project funding
Posted on:
Date limite d´inscription:
Expired
Reference Number
PAR-22-091
The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Categories: Education, Health.
Categories: Education, Health.
États-Unis